Girard Partners Ltd. Gilead Sciences, Inc. Transaction History

Girard Partners Ltd.

$1.06 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$76.01 - $86.7 $5,472 - $6,242	-72 Reduced 2.42%	2,909 $224,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $5,643 - $6,429	73 Added 2.51%	2,981 $247,000
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $181,226 - $260,178	2,908 New	2,908 $0
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $275,804 - $313,043	-4,251 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$67.69 - $73.03 $418,053 - $451,033	-6,176 Reduced 95.43%	296 $296,000
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $267,713 - $288,833	3,955 Added 1336.15%	4,251 $296,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $79,591 - $86,964	-1,254 Reduced 16.23%	6,472 $445,000
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $360 - $410	6 Added 0.08%	7,726 $499,000
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $437,338 - $498,326	7,720 New	7,720 $449,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $254,113 - $319,503	-4,092 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $40,872 - $47,460	-565 Reduced 12.13%	4,092 $314,000
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $17,599 - $22,541	281 Added 6.42%	4,657 $348,000
Q4 2019 Feb 03, 2020	SELL	$61.62 - $67.78 $11,707 - $12,878	-190 Reduced 4.16%	4,376 $284,000
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $324,676 - $358,386	-5,194 Reduced 53.22%	4,566 $289,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $20,478 - $22,964	331 Added 3.51%	9,760 $659,000
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $17,133 - $19,193	274 Added 2.99%	9,429 $613,000
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $302,942 - $395,316	-5,004 Reduced 35.34%	9,155 $572,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $57,736 - $63,925	-810 Reduced 5.41%	14,159 $1.09 Million
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $146,693 - $171,112	-2,261 Reduced 13.12%	14,969 $1.06 Million
Q1 2018 Apr 18, 2018	SELL	$72.84 - $88.8 $311,318 - $379,531	-4,274 Reduced 19.88%	17,230 $1.3 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $390,969 - $458,942	-5,495 Reduced 20.35%	21,504 $1.54 Million
Q3 2017 Nov 08, 2017	SELL	$72.11 - $85.47 $69,514 - $82,393	-964 Reduced 3.45%	26,999 $2.19 Million
Q2 2017 Aug 08, 2017	BUY	N/A	27,963	27,963 $1.98 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Account